Photo by eyeforebony from unsplash
Infantile haemangiomas (IH) are common benign tumours of childhood. The current guideline recommended treatment is oral propranolol, the use of which for IH is relatively recent and there are no… Click to show full abstract
Infantile haemangiomas (IH) are common benign tumours of childhood. The current guideline recommended treatment is oral propranolol, the use of which for IH is relatively recent and there are no safety audits in Australian children published. As a result, it is a primarily inpatient initiated treatment. The aim of this study was to examine the shortâterm complication rates in infants treated with oral propranolol for IH.
Keywords:
rates infants;
propranolol;
infantile haemangiomas;
treated oral;
infants treated;
oral propranolol
Journal Title: Australasian Journal of Dermatology
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Australasian Journal of Dermatology
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!